At Puma Biotechnology, our focus is on bringing innovative therapies to patients to enhance cancer care.
We are thankful to be part of the HER2+ breast cancer community and are passionate about evaluating options that may benefit patients across the breast cancer therapy spectrum.
Location: United States, California, Los Angeles
Employees: 201-500
Total raised: $60M
Founded date: 2010
Investors 1
| Date | Name | Website |
| - | Sahsen Ven... | sahsen.com |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 23.11.2011 | - | $60M | - |
Mentions in press and media 16
| Date | Title | Description | Source |
| 26.07.2021 | Puma Biotechnology : Secures $125 Million Note Purchase by A... | Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that it has entered ... | marketscre... |
| 27.02.2021 | Puma Biotechnology und Pierre Fabre ändern die NERLYNX®-Lize... | LOS ANGELES und CASTRES (Frankreich)--(BUSINESS WIRE)--Feb 27, 2021-- Das Biopharmaunternehmen Puma ... | oaoa.com/n... |
| 10.05.2019 | Puma investors fret, as Nerlynx Q1 sales fall uncomfort... | “We are not pleased with our first-quarter Nerlynx revenues,” Puma Biotechnology chief Alan A... | endpts.com... |
| 19.03.2019 | Affimed lands milestone from Roche; Puma touts new PHII da... | → While Affimed $AFMD works to shake off the FDA hold on its Phase I program, the team is still ma... | endpts.com... |
| 17.07.2017 | Puma’s controversial cancer drug secures FDA approval | On Monday, FDA (somewhat) settled that debate by granting it marketing approval. A tyrosine kinase i... | medcitynew... |
| 24.05.2017 | There’s a therapeutic curveball heading for the FDA | On Wednesday, FDA’s Oncologic Drugs Advisory Committee voted 12-4 in favor of recommending the tyros... | medcitynew... |
| 17.04.2017 | CRISPR Therapeutics, Casebia ink AAV deal with StrideBi... | → CRISPR Therapeutics $CRSP and Casebia Therapeutics, a joint-venture established by CRIS... | endpts.com... |
| 23.11.2011 | Puma Biotechnology Raises $60M | Los Angeles-based Puma Biotechnology, a developer of biopharmaceuticals aimed at treating cancer, sa... | socaltech.... |
| - | Puma’s controversial cancer drug secures FDA approval | The U.S. Food and Drug Administration was forced to draw a line in the sand on Monday, with its appr... | medcitynew... |
| - | Puma Biotechnology et Pierre Fabre amendent leur accord de l... | LOS ANGELES, États-Unis, et CASTRES, France--(BUSINESS WIRE)--févr. 25, 2021-- Puma Biotechnology, I... | oaoa.com/n... |
Show more